VYVANSE lisdexamfetamine dimesilate 20 mg capsules bottle - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
VYVANSE lisdexamfetamine dimesilate 20 mg capsules bottle
AUST R: 284019
Active ingredients:
lisdexamfetamine dimesilate

Dosage form:
Capsule, hard

Sponsor:
Takeda Pharmaceuticals Australia Pty Ltd

Phone:
1800012612

From
14 Jun 2024
to
21 Aug 2024

Shortage status:
Current

Availability:
Limited Availability

Reason:
Unexpected increase in consumer demand

Management action:
The sponsor is closely controlling the supply. The sponsor is working to expedite the next shipment.